DEAL ANNOUNCEMENT
May 14, 2026
Read time: 3 min
McDermott Will & Schulte advises Lorient Capital on investment in PeterMD
Global law firm McDermott Will & Schulte represented Lorient Capital, a private investment firm focused exclusively on healthcare service and technology companies, on its majority equity investment in PeterMD, a direct-to-consumer health optimization platform trusted by more than 400,000 patients. The deal was announced in a press release on May 12.
Lorient’s investment will help accelerate PeterMD’s national expansion in the rapidly growing $200 billion Medicine 3.0 marketplace.
The McDermott team was led by Fred Levenson, Michael Hacker and Jack Beauchamp, with invaluable assistance from Justin Aiello, Dane Chapman, Chelsea Olivera, Prachi Jhunjhunwala, Marshall Jackson, Valeria Chavez, John Zhang, Audrey Pumariega, Alex Ruiz, Melis Solaksubasi, Mark Bilut, Maxwell Preston, Daniel Gottlieb, Haley Dow, Grayson Dimick, James Cannatti, Felicia Alderete, Raja Chatterjee, Maddie San Jose and Sarah Bro.
Leading organizations turn to global law firm McDermott Will & Schulte for a better way to address legal challenges, connect with those at the forefront, and drive stronger outcomes. Working across more than 20 offices globally, our 1,700+ lawyers act on data-driven insights, deep relationships, and unmatched industry experience to deliver on our commitment of Always Better.
